Published in
American Medical Association, JAMA Neurology, 2(71), p. 180
DOI: 10.1001/jamaneurol.2013.4560
Links
- ORCID
- ORCID
- American Medical Association | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [discovery.ucl.ac.uk]
- [europepmc.org] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.duo.uio.no] | PDF
Tools
The role of clusterin in amyloid-β associated neurodegeneration
Journal article published in 2014 by
Rahul S. Desikan,
Wesley K. Thompson,
Dominic Holland,
Christopher P. Hess 
,
James B. Brewer,
Henrik Zetterberg,
Kaj Blennow,
Ole A. Andreassen ,
Linda K. McEvoy,
Bradley T. Hyman,
Anders M. Dale,
Alzheimer’s Disease Neuroimaging Initiative Group
,
James B. Brewer,
Henrik Zetterberg,
Kaj Blennow,
Ole A. Andreassen ,
Linda K. McEvoy,
Bradley T. Hyman,
Anders M. Dale,
Alzheimer’s Disease Neuroimaging Initiative Group
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
Converging evidence indicates that clusterin, a chaperone glycoprotein, influences Alzheimer disease neurodegeneration. However, the precise role of clusterin in Alzheimer disease pathogenesis is still not well understood.